Applied Medical Technology Launches IntelAir™, a Nasopharyngeal Airway

Applied Medical Technology, Inc. (AMT), a global leader in manufacturing medical devices, today announced the debut of IntelAir™, a nasal airway support system. The single-use device is intended to ensure airway securement, avoid cannula migration, and maintain a clear airway.

Used during monitored anesthesia to support the soft palate and tongue in sedated patients, the IntelAir™ champions both clinician needs and patient comfort. Its anatomical shape is designed to reduce bleeding and trauma during insertion. The medical-grade silicone bolster and gentle adhesive attach to the nose while protecting the ala against pressure injury. Of interest to clinicians, the device provides protection against tube migration, reliable oxygen delivery, and consistent end tidal monitoring.

We designed the IntelAir™ to fulfill a market need; while some devices focused on patient needs and others on clinician needs, none appropriately served both. With this all-in-one device, users can benefit from the streamlined approach paired with AMT’s commitment to excellence,” reflected Dr. George Picha M.D., Ph.D., F.A.C.S., Founder & CEO of Applied Medical Technology, Inc.

AMT adds the IntelAir™ to its ever-growing surgical line portfolio, which includes suture delivery systems, initial placement kits, smoke evacuators, retractors, and more.

The IntelAir™ is available for sale now with and without tubing in varying lengths.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”